Afdhal, Nezam <br/><br/>
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.  [electronic resource] 

 -  The New England journal of medicine  Apr 2014 
 - 1483-93 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1316366  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--adverse effects<br/>Benzimidazoles--administration & dosage<br/>Drug Combinations<br/>Female<br/>Fluorenes--administration & dosage<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Nucleotidyltransferases--antagonists & inhibitors<br/>RNA-Dependent RNA Polymerase--antagonists & inhibitors<br/>Sofosbuvir<br/>Uridine Monophosphate--administration & dosage<br/>Viral Load<br/>Viral Nonstructural Proteins--antagonists & inhibitors